PWTYX
Price
$50.73
Change
-$0.45 (-0.88%)
Updated
Jun 13 closing price
Net Assets
211.64M
RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

PWTYX vs RLBCX

Header iconPWTYX vs RLBCX Comparison
Open Charts PWTYX vs RLBCXBanner chart's image
UBS US Allocation P
Price$50.73
Change-$0.45 (-0.88%)
VolumeN/A
Net Assets211.64M
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
PWTYX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PWTYX vs. RLBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PWTYX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. PWTYX (212M). PWTYX pays higher dividends than RLBCX: PWTYX (1.84) vs RLBCX (1.63). PWTYX was incepted earlier than RLBCX: PWTYX (32 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PWTYX (0.77). PWTYX is a more actively managed with annual turnover of: 58.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than PWTYX: RLBCX (250) vs PWTYX (2000000). RLBCX annual gain was more profitable for investors over the last year : 4.94 vs. PWTYX (0.37). RLBCX return over 5 years is better than : 36.51 vs. PWTYX (11.04).
PWTYXRLBCXPWTYX / RLBCX
Total Expense Ratio0.770.8987%
Annual Report Gross Expense Ratio0.770.8987%
Fund Existence32 years23 years-
Gain YTD0.3964.2949%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets212M244B0%
Annual Yield % from dividends1.841.63112%
Returns for 1 year0.374.947%
Returns for 3 years17.6631.5456%
Returns for 5 years11.0436.5130%
Returns for 10 years32.3054.9959%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.200.02
+1.69%
Pacific Biosciences of California
MOH298.144.66
+1.59%
Molina Healthcare
OVID0.28-0.01
-3.15%
Ovid Therapeutics
QSG10.95-0.56
-4.87%
QuantaSing Group Limited
TRIP13.30-0.70
-5.00%
TripAdvisor